SCHEMBL16626441

SCHEMBL16626441

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3cc(F)c(C(F)(F)F)cc3F)ccc12

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 4/20 0.36
IDE P14735 1/20 0.35
HTR6 P50406 3/20 0.34
KMT2A Q03164 1/20 0.34
POLB P06746 1/20 0.33
IDH2 P48735 1/20 0.33
HTT P42858 2/20 0.33
RORC P51449 1/20 0.32
CYP11B2 P19099 1/20 0.32
TSHR P16473 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP3A5 P20815 1/20 0.32
S1PR1 P21453 1/20 0.32
CCR9 P51686 1/20 0.32
METAP2 P50579 1/20 0.31
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618841 0.99 NAMPT (0.35) NAMPTIDEHTR6KMT2APOLB
SCHEMBL16626700 0.92 IDE (0.38) IDEHTR6POLBHTT
Hydrochloric Acid SCHEMBL16619175 0.91 IDE (0.37) IDEHTR6POLBHTT
SCHEMBL16626686 0.89 KMT2A (0.38) NAMPTIDEHTR6KMT2APOLB
SCHEMBL16626403 0.89 KMT2A (0.38) NAMPTIDEHTR6KMT2ACYP11B2
SCHEMBL17971546 0.89 CYP11B2 (0.37) NAMPTIDEHTR6KMT2ACYP11B2
SCHEMBL16626462 0.89 IDE (0.38) NAMPTIDEHTR6POLBHTT
Hydrochloric Acid SCHEMBL16618660 0.89 KMT2A (0.38) NAMPTIDEHTR6KMT2ACYP11B2
Hydrochloric Acid SCHEMBL16619137 0.89 KMT2A (0.38) NAMPTIDEHTR6KMT2ACYP11B2
SCHEMBL16626685 0.89 IDE (0.35) NAMPTIDEHTR6KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI NAMPT 1610/4885IDE 2586/4885HTR6 166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.